This inventor holds 25 USPTO granted patents and 11 published patent applications, primarily in Chemical Synthesis. Top assignees: The Board of Regents of the University of Nebraska, University of Pennsylvania, Ikaria Inc.. Active years: 1994-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Philadelphia, PA (US) (1994 - 1999)
- Lincoln, NE (US) (1997 - 2016)
- Chicago, IL (US) (2018 - 2024)
Company Filing History:
13 out of 968 
9 out of 2,659 
2 out of 7 
Years Active: 1994-2024
Areas of Expertise:
Title: Innovations by Stephen Gregory DiMagno: A Leader in Modified Polypeptides and Drug Delivery Systems
Introduction
Stephen Gregory DiMagno is a prominent inventor based in Lincoln, NE, who has made significant contributions to the field of biomedical engineering and therapeutic development. With a remarkable portfolio of 25 patents, DiMagno has demonstrated his dedication to advancing medical science through innovative solutions.
Latest Patents
Among his notable recent patents, DiMagno has developed a method for creating functionally modified polypeptides. This invention focuses on utilizing non-natural amino acids (nnAAs) within genetic machinery to produce modified polypeptides, which are particularly effective in therapeutic scenarios. Notably, the modified polypeptides are designed to bind to serum albumin, enhancing their utility in drug delivery.
Another significant invention encompasses a drug delivery system utilizing HPMA-CBz copolymers. This system provides methods for treating various diseases by administering these copolymers to affected subjects, showcasing DiMagno's commitment to addressing complex health challenges.
Career Highlights
DiMagno's career has been marked by his association with esteemed institutions, including the University of Pennsylvania and Nutech Ventures. These experiences have not only contributed to his personal growth as an inventor but have also played a crucial role in the development and advancement of his groundbreaking patents.
Collaborations
Throughout his innovative journey, DiMagno has collaborated with talented individuals, including Michael J Therien and Haoran Sun. These partnerships have enriched his work and contributed to the successful realization of several of his inventive projects.
Conclusion
Stephen Gregory DiMagno continues to be a pivotal figure in the field of biotechnology, with his patents paving the way for future treatments and therapies. His focus on innovative drug delivery systems and modified polypeptides reflects a significant step forward in enhancing therapeutic efficacy and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile